ArticleOphthalmology science2026
Peripapillary Choroidal Vascularity Index for Differentiating Papilledema from Pseudopapilledema: A Deep Learning-Based Approach.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Purpose: To compare the peripapillary choroidal vascularity index (PPCVI) in eyes with papilledema secondary to idiopathic intracranial hypertension (IIH) and pseudopapilledema due to optic disc drusen (ODD) using a novel deep learning algorithm. Design: A retrospective observational cohort study. Subjects: The study included 30 eyes of 15 patients with papilledema secondary to IIH, 30 eyes of 15 patients with ODD, and 78 eyes of 39 age- and sex-matched healthy controls. All cases of IIH and ODD were confirmed with lumbar puncture and B-scan ultrasonography, respectively. Methods: OCT was performed using a 3.4 mm diameter 360° peripapillary circle scan. Choroidal segmentation was automatically performed with a deep learning ResUNet model and a volumetric smoothing algorithm. The choroidal vascularity index was quantified in each peripapillary scan. Statistical comparisons were made between groups and in IIH patients before and after resolution of papilledema. Linear mixed models were used for analysis. Main Outcome Measures: Mean PPCVI, expressed as a percentage, across study groups and longitudinally in IIH eyes. Results: There were no significant differences among groups regarding age, sex, visual acuity, or intraocular pressure ( Conclusions: Reduced PPCVI could be a potential biomarker for differentiating papilledema from pseudopapilledema. An increase in PPCVI after resolution of papilledema supports its utility as a potential parameter for monitoring disease activity. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.